methotrexate has been researched along with Hepatic Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiwata, S; Kuroda, M; Migita, K; Miyata, M; Ohira, H; Tasaki, K | 1 |
| Dybała, A; Mosiewicz, J; Myśliński, W; Prystupa, A; Zak, K | 1 |
| Grünhage, F; Lammert, F; Lüttges, J; Schuster, M | 1 |
| Csóka, M; Csordás, K; Eipel, O; Hegyi, M; Kovács, G; Pap, E | 1 |
| Hilsden, RJ; Swain, MG; Urbanski, SJ | 1 |
| Alarcón, GS; Dreyer, NA; Funch, D; Kremer, JM; Lee, RG; Tolman, KG; Walker, AM; Weinblatt, ME | 1 |
| Burge, S; Sheerin, S; Stone, N | 1 |
| Dunn, R; Ferrara, J; Hutchinson, RJ; Levine, JE; Ratanatharathorn, V; Yanik, G | 1 |
8 other study(ies) available for methotrexate and Hepatic Failure
| Article | Year |
|---|---|
Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Female; Humans; Liver Failure; Methotrexate; Non-alcoholic Fatty Liver Disease | 2023 |
[Pancytopenia after methotrexate treatment].
Topics: Aged; Bone Marrow Diseases; Fatal Outcome; Female; Humans; Liver Failure; Methotrexate; Pancytopenia; Spinal Diseases | 2009 |
[50-year-old patient with intermittent fever and liver failure].
Topics: Biopsy; C-Reactive Protein; Calcitonin; Diagnosis, Differential; Ferritins; Fever of Unknown Origin; Humans; Immunosuppressive Agents; Liver; Liver Failure; Liver Function Tests; Male; Methotrexate; Middle Aged; Prednisolone; Protein Precursors; Still's Disease, Adult-Onset | 2011 |
[Pharmacokinetic analysis of high-dose methotrexate treatments in children with hematologic malignancies].
Topics: Adolescent; Antimetabolites, Antineoplastic; Blood Proteins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Creatinine; Drug Administration Schedule; Female; Humans; Kidney; Liver; Liver Failure; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency; Stomatitis; Time Factors; Treatment Outcome | 2011 |
End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency.
Topics: Aged; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Arthritis, Rheumatoid; Biopsy; Chronic Disease; Heterozygote; Humans; Liver; Liver Cirrhosis; Liver Failure; Male; Methotrexate; Phenotype | 1995 |
Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Case-Control Studies; Female; Humans; Incidence; Liver Cirrhosis; Liver Failure; Liver Function Tests; Male; Methotrexate; Middle Aged; Prognosis; Risk Factors | 1993 |
Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Diagnosis, Differential; Diarrhea; Fatal Outcome; Fever; Graft vs Host Disease; Humans; Liver Failure; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency; Stevens-Johnson Syndrome | 1999 |
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Child; Child, Preschool; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infections; Liver Failure; Magnesium Deficiency; Male; Methotrexate; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Vascular Diseases | 2000 |